Financial Statements/ESG Information - [Annual Report / Environmental, Social and Governance Information/Report]

Lepu Biopharma Co Ltd operates as a biopharmaceutical company focusing on oncology therapeutics. The Company serves the unmet medical needs of cancer patients. Lepu Biopharma combines in-house research, development, and strategic collaborations to strengthen in-house manufacturing, and commercialize pipeline products through sales and marketing.

2023 Annual Report

Announcements and Notices - [Other - Business Update]

Voluntary Announcement
Update On The License Agreement With
Astrazeneca For Cmg901

Announcements and Notices - [Final Results]

Annual Results Announcement
For The Year Ended December 31, 2023

Announcements and Notices - [Date of Board Meeting]

Lepu Biopharma (2157 HK)

2023 Annual Report

Voluntary Announcement Update On The License Agreement With Astrazeneca For Cmg901

Annual Results Announcement For The Year Ended December 31, 2023

Notice Of Board Meeting

Voluntary Announcement Fast Track Designation Granted By The Fda To Mrg004a For The Treatment Of Pancreatic Cancer